Does feedback from a medical test help people quit smoking?

01

The intervention is the feedback, not just the measurement

In a fictional comparison, both groups receive the same cessation support, but one also receives a measurement with a tailored explanation. The research asks whether that added feedback changes smoking outcomes. If one group also receives more counselling, its result cannot automatically be attributed to the report alone. The table separates four feedback families, not four tests to request.

A measurement used to detect disease, one used to verify a study outcome and one explained to encourage quitting do different jobs. Evidence about the third purpose cannot establish or dismiss the first two. This page does not interpret a personal result or describe how to perform a test.

[1][2][3]

02

The pooled evidence is not uniformly negative

The 2019 Cochrane review searched in 2018 and included 20 trials with 21 interventions, assessed at least six months after intervention began. CO-exposure feedback showed no clear benefit with moderate-certainty evidence; genetic-risk feedback was uncertain with low-certainty evidence. Lung-function or carotid-damage feedback favoured intervention numerically but its interval included no effect. Excluding high-risk-of-bias studies made that last analysis favourable. That signal should neither be erased nor made a universal promise.

A separate 2022 review, searched to July 2021, examined showing and explaining people's own medical images. Eight smoking-outcome studies favoured non-smoking status, with moderate-certainty evidence. Mostly cardiovascular images, plus one oral-imaging study, were involved—not eight chest-scan studies. Outcomes included current smoking status or cessation among known smokers, not one uniform definition of continuous abstinence. This is not a reason to obtain unnecessary imaging or to use generic frightening pictures.

[1][2]

03

A later lung-age trial shows why the time point matters

The 2023 Breathe Well report compared very brief advice alone with advice plus lung-age or exhaled-CO feedback in North Macedonian primary care. Participants were adults aged at least 35 who smoked at least ten cigarettes daily, whether or not ready to quit. At four weeks, the primary outcome—biochemically checked non-smoking during the previous seven days—did not show a clear added benefit. Few people quit, leaving imprecise estimates.

At 26 weeks, the secondary lung-age comparison was favourable, but the confidence interval was very wide. This again meant biochemically checked non-smoking in the preceding seven days, not uninterrupted abstinence for all 26 weeks. Short-term self-reported reduction also favoured feedback; reduction is not cessation. Neither ‘everything was negative’ nor ‘lung-age feedback reliably works’ describes this trial. Its setting, available support and outcome definitions limit generalization.

[3]

04

Take the purpose question to a professional, not a number to this page

Useful questions are: ‘Is this test proposed for a clinical reason, or as feedback? What would its result change in my care? What cessation support is available with or without it?’ A result described as normal is not a guarantee about future health or permission to keep smoking. Uncertain feedback benefits are not a reason to reject clinically indicated investigation; its need and interpretation belong with a qualified professional.

NHS Better Health lists local Stop Smoking Services in England. Confirm availability, eligibility and the service's scope; the listing does not certify a particular feedback method or promise access to tests. Do not send reports, images, genetic information or health history to this page. It collects and interprets none of them.

[1][2][3][4]

05

What to keep in mind

• Keep favourable findings and their limits together.
• Test purpose and feedback effect are separate questions.
• A report is not a prerequisite for asking about support.